http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I745625-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ce8c2877f407be4d18f72ab84ffaec7 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-576 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7004 |
| filingDate | 2018-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82bae1232de6c595703ded34d67123b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5be2ac7be2239bae4f77b312607d111e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a661dd76ffdc0b0815333470fcde13e8 |
| publicationDate | 2021-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-I745625-B |
| titleOfInvention | A galactose oral composition and its application |
| abstract | A galactose oral composition comprising galactose, and a buffer solution; wherein the galactose oral composition contains 1% to 80% by weight of galactose. The antioxidant is selected from the group consisting of Vitamin A, Vitamin C, Vitamin E, sodium bisulfite, flavonoids, polyphenols, nEthylenediaminetetraacetic acid (EDTA), Diethylenetriaminepentaacetic acid (DTPA), and NTA -Nitrilotriacetate acid (NTA). The buffer solution is selected from the group consisting of citrate buffer, phosphate buffer, acetate buffer, carbonate buffer, ascorbic acid buffer, and triethanolamine buffer. The galactose oral composition can be applied to detect individual galactose removal ability to assess liver function. |
| priorityDate | 2018-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 104.